Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

This study has been terminated.
National Council of Science and Technology, Mexico
Psicofarma S.A. de C.V.
Information provided by:
National Institute of Cancerología Identifier:
First received: November 1, 2006
Last updated: NA
Last verified: November 2006
History: No changes posted